Epilepsy Trials in Nashville, United States
Conditions / Epilepsy / Nashville, United States
Epilepsy is a medical condition with active clinical research programs worldwide.
42 total trials for this combination
Showing top 10 of 42 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00910247 | Eslicarbazepine Acetate Monotherapy Long Term Study | COMPLETED | PHASE3 |
| NCT00520741 | Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures | COMPLETED | PHASE3 |
| NCT00334958 | Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures | COMPLETED | PHASE3 |
| NCT00530855 | Trial to Assess Long-term Lacosamide (LCM) Monotherapy Use and Safety of LCM Monotherapy and Adjunctive Therapy for Partial-onset Seizures | COMPLETED | PHASE3 |
| NCT01999777 | Study to Evaluate the Safety and Efficacy of USL261 in Patients With Increased Bouts of Seizure Activity in the EMU | COMPLETED | PHASE3 |
| NCT01339559 | Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Epilepsy | COMPLETED | PHASE3 |
| NCT00464269 | Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures | COMPLETED | PHASE3 |
| NCT00150800 | This Trial, Evaluating the Long-term Safety and Tolerability of Brivaracetam Will Provide Subjects Suffering From Epilepsy, Who May Have Benefited From Brivaracetam as Adjunctive Treatment, the Opportunity to Receive Open Label Brivaracetam Treatment | COMPLETED | PHASE3 |
| NCT01390220 | Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters | TERMINATED | PHASE3 |
| NCT00319501 | Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures. | COMPLETED | PHASE3 |